Benchling enables experimental traceability for Dragonfly Therapeutics
Robert Ruidera at Dragonfly Therapeutics highlights the use of Benchling in their work on NK engager therapeutics focused on tri-specific antibodies. Adopting Benchling resolved Dragonfly’s issues with tracking information required by the FDA for an IND filing. Benchling’s ability to hash out individual experiments allows Ruidera’s team manager to easily locate specific experiments needed for targeted reports.
Simplifies the process of tracking materials and methods across different experiments
Allows team to abstract specific characteristics from donors, identifying phenotypes that enhance drug response
Enables easy tracking of development of specific molecules